InvestorsHub Logo

Investor100

01/14/17 11:17 PM

#1486 RE: Investor100 #1485

Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) current consensus investment analysts is to Buy


http://theindependentrepublic.com/2017/01/12/immune-pharmaceuticals-inc-nasdaqimnp-current-consensus-investment-analysts-is-to-buy-3/


Investor 100